Jose Sandoval‐Sus

机构：Moffitt Cancer Center, Memorial Healthcare System · ORCID：0000-0001-5815-7471

发表论文 146 篇 · 总被引 1051 次 · h-index 17

代表论文

• ABCL-777: Initial Results From LOTIS-7: A Phase 1b Study of Loncastuximab Tesirine Plus Glofitamab in Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) (2025 · Clinical Lymphoma Myeloma & Leukemia · 被引 8)
• Treatment-related outcomes and patterns of relapse in secondary CNS involvement by large B-cell lymphoma (2026 · Blood · 被引 4)
• Epcoritamab monotherapy for Richter transformation (EPCORE CLL-1): findings from a single-arm, multicentre, open-label, phase 1b/2 trial (2025 · The Lancet Haematology · 被引 4)
• Final results of a multicentre pilot study evaluating brentuximab vedotin with cyclophosphamide, doxorubicin, etoposide and prednisone ( BV ‐ CHEP ) for the treatment of aggressive adult T‐cell leukaemia/lymphoma (2025 · British Journal of Haematology · 被引 1)
• 339 | OUTCOMES IN AN INTERNATIONAL MULTICENTRE STUDY OF 600 PATIENTS WITH CNS RELAPSE OF LARGE B CELL LYMPHOMA: COMPARTMENT OF RELAPSE IS PROGNOSTIC (2025 · Hematological Oncology · 被引 1)
• The Influence of Racial, Socioeconomic, and Geographic Disparities in the Survival of Patients With Plasmablastic Lymphoma: A Population-Based Analysis From the Surveillance, Epidemiology, and End Results (SEER) Database (2000-2022) (2026 · Clinical Lymphoma Myeloma & Leukemia)